AbbVie’s Rinvoq tops Dupixent in eczema showdown, but safety issues will limit use, analysts say chelfand Fri, 12/11/2020 – 11:58 More: AbbVie's Rinvoq tops Dupixent in eczema showdown, but safety issues will limit use, analysts say Source: fierce
read morePfizer-Mylan combo Viatris to slash up to 9,000 jobs, shutter manufacturing plants in global cost-cutting drive fkansteiner Fri, 12/11/2020 – 11:30 More: Pfizer-Mylan combo Viatris to slash up to 9,000 jobs, shutter manufacturing plants in global cost-cutting drive Source: fierce
read moreFDA reviewers argue for Novartis ahead of Entresto advisory panel confab aliu Fri, 12/11/2020 – 11:12 More: FDA reviewers argue for Novartis ahead of Entresto advisory panel confab Source: fierce
read moreLundbeck taps Mental Health America—and its big data—to create a national crisis dashboard bbulik Fri, 12/11/2020 – 11:09 More: Lundbeck taps Mental Health America—and its big data—to create a national crisis dashboard Source: fierce
read moreNovartis’ $9.7B MedCo buyout bears first fruit as blockbuster-to-be inclisiran nabs EU nod aliu Fri, 12/11/2020 – 08:53 More: Novartis' .7B MedCo buyout bears first fruit as blockbuster-to-be inclisiran nabs EU nod Source: fierce
read moreIf approved, drug will become first treatment for PFIC patients in the US and EU More: Albireo submits rare liver disease med odevixibat to FDA and EMA Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals